-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Avadel Pharmaceuticals Plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Avadel Pharmaceuticals Plc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$5.04M, a 82.5% increase year-over-year.
- Avadel Pharmaceuticals Plc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$48.8M, a 69.5% increase year-over-year.
- Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2024 was -$48.8M, a 69.5% increase from 2023.
- Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$160M, a 16.6% decline from 2022.
- Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$137M, a 77.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)